First-line chemotherapy in low-risk gestational trophoblastic neoplasia-Reference-Cited by-同舟云学术

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Published:2012-07-11 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Alazzam Mo'iad,Tidy John,Hancock Barry W,Osborne Raymond,Lawrie Theresa A

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007102.pub3/epdf/full

Reference70 articles.

1. Gilani MM Yarandi F Eftekhar Z Hanjani P Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia Australian and New Zealand Journal of Obstetrics and Gynaecology 2005 161 4

2. Actinomycin D versus methotrexate-folinic acid as the treatment of stage 1, low-risk gestational trophoblastic neoplasia;Lertkhachonsuk,2007

3. Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial;Lertkhachonsuk;International Journal of Gynecological Cancer,2009

4. Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease;Mousavi;International Journal of Gynecology and Obstetrics,2012

5. A randomized phase III trial comparing weekly parenteral methotrexate and “pulsed” dactinomycin as primary management for low-risk gestational trophoblastic neoplasia: A Gynecologic Oncology Group study;Osborne,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy;Current Treatment Options in Oncology;2024-07-25

2. Gestational Trophoblastic Disease;Tata Memorial Centre Textbook of Oncology;2024

3. Successful Management of Persistent Gestational Trophoblastic Neoplasia: A Comprehensive Review and Case Analysis;Cureus;2023-12-26

4. Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN);Gynecologic Oncology;2023-08

5. Diagnosis and Management of Gestational Trophoblastic Disease;Handbook of Gynecology;2023